Jump to any asset
850 assets, updated daily
As of September 11, 2026, Brown & Brown Inc. (BRO) trades at $65.65. CleaRank Financial AI rates it Hold with a fair value of $77.00, 17.3% above the current price. Wall Street's consensus target is $77.00 across 19 analysts. RSI at 27 is in oversold territory, and the price is below its 50-day average of $70.17.
Brown & Brown Inc. (BRO)
Brown & Brown Inc. NYSE
$65.65
-0.6800 (-1.03%)
Latest Price
AI Analyst Consensus
57 / 100
Brown & Brown Inc. (BRO) is currently trading at $65.65, below its 50-day and 200-day moving averages ($70.17 and $69.19), signaling technical weakness. The company's revenue growth has been strong, with current year estimates at +18.00% year-over-year, outpacing the sector median of 11.7%. However, the stock's price action and a mixed Wall Street consensus suggest a cautious approach is warranted. Despite the technical headwinds, insider activity shows a net buying signal, with $505.4K in purchases versus no reported sales, indicating some level of internal confidence. The company's earnings have been largely in line with estimates, with the most recent quarter showing a 0% surprise. The insurance brokerage sector, while generally stable, faces ongoing regulatory scrutiny and evolving market dynamics.
BRO Price Analysis
Market Metrics
Open
$67.69
Day Range
$65.42 to $67.69
Prev Close
$66.33
Volume
28.9K
52-Week Range
$53.81 to $97.49
Market Cap
$22.19B
Peer Benchmarking
Valuation vs Sector (Financial Services)
Performance vs KBE
Sector Position Analysis
Trading at a significant premium to sector peers (+28%), suggesting market expectations for superior growth or market position.
BRO Analysis
Company's Health
4/5
12-Month Analyst Target
+17.29% Upside
Median of 19 analysts (12-month)
$77.00
AI Technical Analysis
Brown & Brown Inc. is trading below its 50-day and 200-day moving averages ($70.17 and $69.19), indicating a bearish trend. The Relative Strength Index (RSI) is at 26.62, firmly in oversold territory, suggesting a potential for a short-term bounce. MACD is also negative, reinforcing the current bearish momentum. Key support levels are not clearly defined given the recent price action, but the oversold RSI may offer some near-term respite. Volume has been significantly below average recently, which could indicate a lack of conviction from either buyers or sellers. Investors should monitor for a sustained move back above the 50-day SMA for signs of a trend reversal.
ProTips
- Monitor the stock's ability to reclaim its 50-day and 200-day moving averages for signs of a trend reversal.
- Given the current oversold RSI, a short-term technical bounce is possible, but sustained upside will depend on fundamental catalysts.
- As an insurance broker, Brown & Brown Inc. is sensitive to interest rate environments and regulatory changes; stay informed on sector-specific news.
Key Catalysts
Bullish
Positive Insider Buying Trend
Insiders have made net purchases totaling $505.4K with no reported sales, signaling confidence in the company's future performance.
Source: Insider Trading DataBullish
Strong Revenue Growth Projections
Current year revenue estimates show a projected growth of 18.00%, significantly exceeding the sector median and indicating strong business expansion.
Source: Wall Street EstimatesBearish
Trading Below Key Moving Averages
The stock is currently positioned below its 50-day and 200-day moving averages ($70.17 and $69.19), indicating a bearish technical trend and potential for further price depreciation.
Source: Technical AnalysisBearish
Valuation Premium Relative to Sector
Brown & Brown Inc.'s P/E ratio of 21.19 is higher than the sector median of 16.5, suggesting it may be overvalued compared to peers.
Source: Fundamental AnalysisMarket Outlook
The base case for Brown & Brown Inc. over the next 6-12 months anticipates a potential recovery driven by its strong revenue growth and positive insider sentiment, provided the stock can overcome its current technical resistance. The median analyst price target of $77.00 suggests a potential upside of 17.3% from current levels. The company's ability to maintain its growth trajectory and meet forward revenue estimates will be key. However, a shift in market sentiment or a failure to break through its moving averages could lead to further downside. Key catalysts for upside include continued strong earnings beats and positive analyst rating changes, while downside risks involve increased competition, regulatory changes impacting the insurance sector, or a broader market downturn that disproportionately affects higher-valued stocks.
Key Statistics
| Market Cap | 22.19B |
|---|---|
| P/E Ratio | 21.19 |
| EPS (TTM) | 3.13 |
| Dividend Yield | 1.00% |
| 52 Week High | 97.49 |
| 52 Week Low | 53.81 |
Brown & Brown Inc. trades at a P/E ratio of 21.19, which is above the sector median of 16.5, suggesting a premium valuation. The company's earnings per share (EPS) of $3.13 is solid, and its revenue growth of 32.4% significantly outpaces the sector average. However, the current price-to-sales ratio implied by its market cap and revenue needs careful consideration against its P/E. The company's balance sheet strength and profitability metrics, such as Return on Equity (ROE), should be evaluated in the context of its valuation. While revenue growth is a strong positive, the premium P/E ratio warrants attention, especially given the current technical weakness.
Earnings & Growth Analysis
Brown & Brown Inc.'s recent earnings reports have shown consistency, with the latest quarter (July 2026) reporting EPS of $1.07, exactly in line with estimates, and a 0% surprise. The prior quarter (April 2026) saw a slight beat of 2.21%. Overall, the company has demonstrated an ability to meet analyst expectations, though significant positive surprises have been infrequent. Forward revenue estimates for the current year project strong growth of 18.00%.
Key Risks
The primary risk for Brown & Brown Inc. is its current technical weakness, trading below key moving averages with an oversold RSI, which could lead to further price declines. Additionally, its P/E ratio of 21.19 is higher than the sector median, indicating a potential valuation stretch that could be vulnerable in a risk-off environment. Competitive pressures within the insurance brokerage sector also pose an ongoing challenge.
Technical Indicators
| RSI (14) | 26.62 |
|---|---|
| MACD | -0.72 |
| SMA 50 | 70.17 |
| SMA 200 | 69.19 |
RSI
Oversold
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Bearish
Golden Cross in effect with the 50-day SMA ($70.17) above the 200-day SMA ($69.19), price is trading below the 50-day SMA, RSI at 26.6 suggests oversold conditions; potential bounce setup.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.12
Weak correlation
Nasdaq 100 (QQQ)
-0.04
Weak correlation
Bitcoin (BTC)
-0.03
Weak correlation
Gold (XAU)
-0.09
Weak correlation
Check Custom Correlation
Calculating correlation...
BRO Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies (click to switch)
CONSERVATIVE
$64.99
Slight discount to current
Wait for small dip
AGGRESSIVE
$65.65
At current price
Enter now if confident
Risk Management
STOP LOSS
$61.27
MAX LOSS
-5.7%
Volatility-Adjusted Stop Loss
Calculated based on RSI (26.6) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$66.94
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$68.24
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$70.19
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for BRO is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 11, 2026.Growth of $10,000
A $10,000 investment in BRO in September 2016 would be worth about $35,404 today, compared with about $35,030 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BRO today could grow to about $26,511 by 2036 in the base case, with a bull case near $70,880 and a bear case around $9,916. Projections are statistical simulations, not guarantees.
BRO Stock Price Prediction: 2030
CleaRank's simulation projects a price near $96.96 for BRO by 2030 in the base case, from $65.65 today (1.5x over 4 years). The downside path ends near $52.06. These are outcomes of a Monte Carlo simulation run on BRO's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $53.03 | $72.37 | $98.77 |
| 2028 | $51.39 | $79.78 | $124 |
| 2029 | $51.33 | $87.96 | $151 |
| 2030 | $52.06 | $96.96 | $181 |
| 2031 | $53.33 | $107 | $214 |
| 2032 | $55.01 | $118 | $252 |
| 2033 | $57.06 | $130 | $296 |
| 2034 | $59.42 | $143 | $345 |
| 2035 | $62.11 | $158 | $401 |
| 2036 | $65.10 | $174 | $465 |
Method: 10,000 simulated price paths using BRO's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
BRO Insider Trading Analysis
Bought
$505.4K
4 Transactions
Sold
None
No open-market sells
Insiders
22
Active Traders
Avg Transaction
$126.4K
Moderate size
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 26, 2024 | BROWN J. HYATT
Chairman of the Board
|
Sell | 418.9K | $46.8M |
| Apr 29, 2021 | BROWN J. HYATT
Chairman of the Board
|
Sell | 850.0K | $43.9M |
| Mar 13, 2024 | BROWN J. HYATT
Chairman of the Board
|
Sell | 236.0K | $20.2M |
| Aug 29, 2024 | BROWN J. HYATT
Chairman of the Board
|
Sell | 134.6K | $14.1M |
| Mar 15, 2018 | BROWN J. HYATT
Chairman of the Board
|
Sell | 140.0K | $7.4M |
| Dec 19, 2019 | PENNY JEROME SCOTT
Officer
|
Sell | 30.0K | $1.2M |
| Nov 23, 2016 | FREEBOURN RICHARD ALISON SR.
Officer
|
Sell | 25.0K | $1.1M |
| Apr 21, 2017 | STRIANESE ANTHONY T
Officer
|
Sell | 24.6K | $1.0M |
| Mar 13, 2019 | STRIANESE ANTHONY T
Officer
|
Sell | 35.0K | $1.0M |
| Jun 24, 2016 | FREEBOURN RICHARD ALISON SR.
Officer
|
Sell | 27.6K | $984.0K |
Page 1 of 1
Frequently Asked Questions
Is Brown & Brown Inc. stock a buy right now?
Brown & Brown Inc. is currently rated Hold by Wall Street analysts and has a consensus score of 57. While insider buying and strong revenue growth are positive, the stock is trading below its key moving averages, indicating technical weakness. The median analyst price target suggests a modest upside of 17.3%.
What is Brown & Brown Inc.'s price target?
The median analyst price target for Brown & Brown Inc. is $77.00, suggesting an upside potential of 17.3% from the current price of $65.65. The price targets range from a low of $60 to a high of $90.
What are the biggest risks for Brown & Brown Inc. stock?
The main risks include current technical weakness, with the stock trading below its 50-day and 200-day moving averages ($70.17 and $69.19), and a P/E ratio that is above the sector median. Competitive pressures within the insurance brokerage industry also present ongoing challenges.
How is Brown & Brown Inc. performing in terms of revenue growth?
Brown & Brown Inc. is demonstrating strong revenue growth, with current year estimates projecting an increase of 18.00% year-over-year, significantly outpacing the sector median of 11.7%.
What is the insider sentiment for Brown & Brown Inc. stock?
Insider sentiment for Brown & Brown Inc. is moderately positive, with insiders being net buyers. Total purchases amount to $505.4K, with no reported sales, indicating a degree of internal confidence in the company's prospects.
How does Brown & Brown Inc. compare to its sector averages?
Brown & Brown Inc. shows stronger revenue growth (32.4%) than the sector median (11.7%) and a higher P/E ratio (21.19 vs. 16.5). Its ROE is also slightly above the sector median (13.8%).
What is the outlook for Brown & Brown Inc. based on earnings?
Brown & Brown Inc.'s recent earnings have been consistent with analyst expectations, with the latest quarter showing a 0% surprise. Forward revenue estimates remain strong, projecting continued growth for the current and next year.